In this second webinar on the topic of canine atopic dermatitis, Dr. Pieper continues his discussion with a focus on moderate to severe cases of disease. His discussion includes:
- Characteristics of moderate to severe disease
- Current therapeutic options including JAK inhibitors (Apoquel and Zenrelia) and when they should be implemented into treatment plans
- The role of monoclonal antibodies and how Cytopoint can be used as part of patient management
- The ideal cases for allergen specific immunotherapy and testing options
Running time: 1 hr 16 mins (including 16 mins of Q&A)
Approved for 1 hour of CE credit by AAVSB RACE and NY State
You might also like
Stem Cell Therapy For Canine Atopic Dermatitis
08/20/2025
Canine atopic dermatitis is a complex disease. Management of patients is often multimodal and includ...
Read
More
Canine Atopic Dermatitis - Pathogenesis, Diagnosis, And Treatment Of Mild Disease
08/12/2025
Canine atopic dermatitis (CAD) is one of the most frustrating and complex skin conditions encountere...
Read
More
The Skinny On Pyoderma - The Most Common Bacterial Infection Of The Skin
08/05/2025
Pyoderma (bacterial skin infection) is one of the most common dermatologic conditions seen in compan...
Read
More
Tackling Itchy And Smelly Ears
07/29/2025
Otitis externa is a common and often recurrent condition affecting the ears of dogs and cats. The co...
Read
More
Quality Of Life And End Of Life Considerations For Cancer Patients And Their Families
12/11/2024
Dr. Kathleen Cooney - a certified veterinary hospice and palliative care veterinarian, end-of-life e...
Read
More
Treating Cancer - It's Not Just Limited To "chemo" Or "radiation"
11/06/2024
There are different approaches to cancer treatment and, for some types of cancer, the therapy may be...
Read
More
